Zhong Guo Ji Jin Bao·2025-12-23 12:32Core Viewpoint - The actual controller of Haohai Biological Technology, Jiang Wei, has been penalized approximately 19.34 million yuan for insider trading and related activities, which includes the confiscation of illegal gains and fines imposed by the China Securities Regulatory Commission [1][2]. Group 1: Penalty Details - Jiang Wei was fined 1.463 million yuan and had illegal gains of 471 million yuan confiscated by the China Securities Regulatory Commission [1][2]. - The penalty is directed at Jiang Wei personally and is stated to have no significant impact on the company's daily operations or financial status [4]. Group 2: Shareholding Structure - As of the end of the third quarter, Jiang Wei holds 66.528 million shares, representing 28.6% of Haohai Biological Technology's total shares [4]. - The top ten shareholders collectively hold 79.3% of the total shares, with Jiang Wei and You Jie being the main controllers of the company [5]. Group 3: Business Developments - Haohai Biological Technology plans to invest 38.3515 million yuan to acquire a 19.8% stake in Jiangxi Ruiji Biological Engineering Technology Co., Ltd., which specializes in the research, production, and sales of biological amniotic membranes [6]. - The investment aims to enhance the company's product portfolio and expand its business coverage in the ophthalmology and orthopedics sectors [6]. Group 4: Financial Performance of Target Company - Ruiji Biological reported a projected net profit of -12.7415 million yuan for 2024, with a loss of 11.9327 million yuan in the first nine months of 2025 [7][8]. - The transaction does not include performance commitments or guarantees, indicating potential risks for Haohai Biological Technology if Ruiji's performance declines [8].